Microbiota-dependent T-cell response to α-synuclein-derived antigens triggers the development of hypersensitivity and neuroinflammation associated with Parkinson's Disease
VCP regulates early tau seed amplification via specific cofactors
The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons
Seeding Activity of Skin Misfolded Tau as a Biomarker for Tauopathies
Heparin-enriched plasma proteome is significantly altered in Alzheimer’s Disease
Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis, and reactive microglia in a dose- and sex-specific manner
Alzheimer’s disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice
Adaptive immune changes associate with clinical progression of Alzheimer’s disease
Apoer2-ICD-dependent regulation of hippocampal ribosome mRNA loading
MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson’s disease